檢索結果 - Paul J. Ross

Refine Results
  1. 1
    Targeting FGF19/FGFR4 Pathway: A Novel Therapeutic Strategy for Hepatocellular Carcinoma

    Targeting FGF19/FGFR4 Pathway: A Novel Therapeutic Strategy for Hepatocellular Carcinoma 由 Dimitra Repana, Paul J. Ross

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions

    Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions 由 Chara Stavraka, Hannah Rush, Paul J. Ross

    出版 2018
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer

    Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer 由 Francesca Negri, A. Wotherspoon, David Cunningham, A. Norman, Geoff Chong, Paul J. Ross

    出版 2005
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient Data

    Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Indiv... 由 Ian Chau, Andy Norman, David Cunningham, Justin S. Waters, Jacqui Oates, Paul J. Ross

    出版 2004
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?

    Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? 由 Paul J. Ross, S. Ashley, A. Norton, K. Priest, Justin S. Waters, Tim Eisen, Ian E. Smith, Mary O’Brien

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    The impact of low-grade toxicity in older people with cancer undergoing chemotherapy

    The impact of low-grade toxicity in older people with cancer undergoing chemotherapy 由 Tania Kalsi, G. Babic-Illman, Paul Fields, Simon Hughes, N. Maisey, Paul J. Ross, Yanzhong Wang, Danielle Harari

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people

    The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people 由 Tania Kalsi, G. Babic-Illman, Paul J. Ross, N. Maisey, Simon Hughes, Paul Fields, Finbarr C. Martin, Yanzhong Wang, Danielle Harari

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

    Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer 由 Sheela Rao, David Cunningham, Robert E. Hawkins, Mark Hill, David B. Smith, F. Daniel, Paul J. Ross, J. Oates, A. Norman

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort

    The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort 由 Paul Nderitu, Cecilia Bosco, Hans Garmo, Lars Holmberg, Håkan Malmström, Niklas Hammar, Göran Walldius, Ingmar Jungner, Paul J. Ross, Mieke Van Hemelrijck

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity

    Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity 由 A Loganayagam, Mónica Hernández, Adele Corrigan, Lynette D. Fairbanks, Cathryn M. Lewis, Peter Harper, N. Maisey, Paul J. Ross, Jeremy Sanderson, Anthony M. Marinaki

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer

    A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer 由 Paul J. Ross, A. Norman, David Cunningham, Andrew Webb, Timothy Iveson, Anwar R. Padhani, J Prendiville, Maggie Watson, Alison Massey, Răzvan Popescu, J. Oates

    出版 1997
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer

    Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer 由 Ian Chau, Gina Brown, David Cunningham, Diana Tait, Andrew Wotherspoon, A. Norman, Niall C. Tebbutt, Mark Hill, Paul J. Ross, Alison Massey, J. Oates

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    The Value of Routine Serum Carcino-Embryonic Antigen Measurement and Computed Tomography in the Surveillance of Patients After Adjuvant Chemotherapy for Colorectal Cancer

    The Value of Routine Serum Carcino-Embryonic Antigen Measurement and Computed Tomography in the Surveillance of Patients After Adjuvant Chemotherapy for Colorectal Cancer 由 Ian Chau, Mark Allen, David Cunningham, A. Norman, Gina Brown, Hugo Ford, Niall C. Tebbutt, Diana Tait, Mark Hill, Paul J. Ross, Jacqui Oates

    出版 2004
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study

    Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study 由 Thierry André, Jose M. Reyes-Vidal, Lætitia Fartoux, Paul J. Ross, Myles Leslie, Olivier Rosmorduc, Michael Clemens, Christophe Louvet, N. Perez, Faisal Mehmud, Werner Scheithauer

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials

    Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials 由 Gunnar Folprecht, David Cunningham, Paul J. Ross, Bengt Glimelius, Francesco Di Costanzo, J. Wils, Werner Scheithauer, P Rougier, Enrique Aranda, Hartmut Hecker, C.-H. Köhne

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials

    Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials 由 Ángela Lamarca, Paul J. Ross, Harpreet Wasan, Richard Hubner, Mairéad G. McNamara, Andre Lopes, Prakash Manoharan, Daniel G. Palmer, John Bridgewater, Juan W. Valle

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Search: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients with Hepatocellular Carcinoma (HCC)

    Search: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients with Hepatocellular Carcinoma (HCC) 由 Andrew X. Zhu, Olivier Rosmorduc, J Evans, Paul J. Ross, Antonino Santoro, F.J. Carrilho, M. Leberre, Maj‐Britt Jensen, Gudrun Meinhardt, Yu-chen Kang

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer

    A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer 由 Ian Chau, A. Norman, David Cunningham, Diana Tait, Paul J. Ross, Timothy Iveson, Mark Hill, Tamas Hickish, F. Lofts, Duncan I. Jodrell, Andrew Webb, J. Oates

    出版 2005
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer

    Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer 由 Andrea Saini, A. Norman, David Cunningham, Ian Chau, Mark Hill, Diana Tait, Tamas Hickish, Timothy Iveson, F. Lofts, Duncan I. Jodrell, Paul J. Ross, J. Oates

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma

    SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma 由 Andrew X. Zhu, Olivier Rosmorduc, T.R. Jeffry Evans, Paul J. Ross, Armando Santoro, Flair José Carrilho, Jordi Bruix, Shukui Qin, Paul J. Thuluvath, Josep M. Llovet, Marie-Aude LeBerre, Markus Jensen, Gerold Meinhardt, Yoon‐Koo Kang

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: